Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.
Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical development.
The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance for their merger.
AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA...
Japanese pharma company Yamanouchi has struck a deal to co-market its forthcoming overactive bladder treatment with GlaxoSmithKline in the US.
Exanta on NICE list ahead of marketing authorisation
Aventis has gone to court in the US to prevent generic versions of its second-biggest drug, blockbuster anti-thrombotic treatment Lovenox, coming to...
Patients would benefit from less involvement between pharmaceutical companies and the medical profession, according to new research.
Roche new mart pillXeloda has been recommended by NICE for the treatment of advanced breast and bowel cancer.
The Government has conceded to intense pressure to give patients input into a new inquiry on the safety of SSRI antidepressants.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches